vs

Side-by-side financial comparison of Quest Resource Holding Corp (QRHC) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.

SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $58.9M, roughly 1.1× Quest Resource Holding Corp). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs -2.8%, a 42.2% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $1.0M).

Quest Resource Holding Corp provides end-to-end waste management, recycling, and sustainability solutions to commercial, industrial, and retail clients across North America. It helps businesses cut waste volumes, reduce operational costs, and fulfill corporate environmental targets via customized waste diversion and circular economy initiatives.

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

QRHC vs SLNO — Head-to-Head

Bigger by revenue
SLNO
SLNO
1.1× larger
SLNO
$66.0M
$58.9M
QRHC
Higher net margin
SLNO
SLNO
42.2% more per $
SLNO
39.4%
-2.8%
QRHC
More free cash flow
SLNO
SLNO
$42.4M more FCF
SLNO
$43.5M
$1.0M
QRHC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
QRHC
QRHC
SLNO
SLNO
Revenue
$58.9M
$66.0M
Net Profit
$-1.7M
$26.0M
Gross Margin
15.5%
98.3%
Operating Margin
0.9%
33.5%
Net Margin
-2.8%
39.4%
Revenue YoY
-15.8%
Net Profit YoY
82.6%
134.0%
EPS (diluted)
$-0.08
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QRHC
QRHC
SLNO
SLNO
Q4 25
$58.9M
Q3 25
$63.3M
$66.0M
Q2 25
$59.5M
$32.7M
Q1 25
$68.4M
Q4 24
$70.0M
Q3 24
$72.8M
Q2 24
$73.1M
Q1 24
$72.7M
Net Profit
QRHC
QRHC
SLNO
SLNO
Q4 25
$-1.7M
Q3 25
$-1.3M
$26.0M
Q2 25
$-2.0M
$-4.7M
Q1 25
$-10.4M
Q4 24
$-9.5M
Q3 24
$-3.4M
Q2 24
$-1.5M
Q1 24
$-655.0K
Gross Margin
QRHC
QRHC
SLNO
SLNO
Q4 25
15.5%
Q3 25
18.1%
98.3%
Q2 25
18.5%
97.9%
Q1 25
16.0%
Q4 24
15.3%
Q3 24
16.1%
Q2 24
18.5%
Q1 24
19.3%
Operating Margin
QRHC
QRHC
SLNO
SLNO
Q4 25
0.9%
Q3 25
1.7%
33.5%
Q2 25
0.6%
-20.0%
Q1 25
-11.9%
Q4 24
-10.3%
Q3 24
-1.3%
Q2 24
2.4%
Q1 24
2.6%
Net Margin
QRHC
QRHC
SLNO
SLNO
Q4 25
-2.8%
Q3 25
-2.1%
39.4%
Q2 25
-3.3%
-14.4%
Q1 25
-15.2%
Q4 24
-13.6%
Q3 24
-4.7%
Q2 24
-2.1%
Q1 24
-0.9%
EPS (diluted)
QRHC
QRHC
SLNO
SLNO
Q4 25
$-0.08
Q3 25
$-0.06
$0.47
Q2 25
$-0.09
$-0.09
Q1 25
$-0.50
Q4 24
$-0.47
Q3 24
$-0.16
Q2 24
$-0.07
Q1 24
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QRHC
QRHC
SLNO
SLNO
Cash + ST InvestmentsLiquidity on hand
$1.0M
$498.9M
Total DebtLower is stronger
$64.0M
Stockholders' EquityBook value
$40.5M
$494.8M
Total Assets
$145.6M
$599.9M
Debt / EquityLower = less leverage
1.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QRHC
QRHC
SLNO
SLNO
Q4 25
$1.0M
Q3 25
$1.1M
$498.9M
Q2 25
$449.0K
$286.8M
Q1 25
$1.4M
Q4 24
$396.0K
Q3 24
$1.1M
Q2 24
$957.5K
Q1 24
$581.1K
Total Debt
QRHC
QRHC
SLNO
SLNO
Q4 25
$64.0M
Q3 25
$65.4M
Q2 25
$69.7M
Q1 25
$74.1M
Q4 24
$76.3M
Q3 24
$71.9M
Q2 24
$70.7M
Q1 24
$68.5M
Stockholders' Equity
QRHC
QRHC
SLNO
SLNO
Q4 25
$40.5M
Q3 25
$42.0M
$494.8M
Q2 25
$42.9M
$240.1M
Q1 25
$44.4M
Q4 24
$54.2M
Q3 24
$62.8M
Q2 24
$65.6M
Q1 24
$66.3M
Total Assets
QRHC
QRHC
SLNO
SLNO
Q4 25
$145.6M
Q3 25
$149.3M
$599.9M
Q2 25
$153.1M
$332.3M
Q1 25
$165.7M
Q4 24
$175.6M
Q3 24
$178.2M
Q2 24
$181.8M
Q1 24
$179.0M
Debt / Equity
QRHC
QRHC
SLNO
SLNO
Q4 25
1.58×
Q3 25
1.56×
Q2 25
1.62×
Q1 25
1.67×
Q4 24
1.41×
Q3 24
1.15×
Q2 24
1.08×
Q1 24
1.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QRHC
QRHC
SLNO
SLNO
Operating Cash FlowLast quarter
$1.1M
$43.5M
Free Cash FlowOCF − Capex
$1.0M
$43.5M
FCF MarginFCF / Revenue
1.7%
65.8%
Capex IntensityCapex / Revenue
0.1%
0.0%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters
$9.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QRHC
QRHC
SLNO
SLNO
Q4 25
$1.1M
Q3 25
$5.7M
$43.5M
Q2 25
$3.9M
$-12.6M
Q1 25
$-1.1M
Q4 24
$-4.8M
Q3 24
$-475.0K
Q2 24
$808.0K
Q1 24
$-1.7M
Free Cash Flow
QRHC
QRHC
SLNO
SLNO
Q4 25
$1.0M
Q3 25
$5.6M
$43.5M
Q2 25
$3.9M
$-12.6M
Q1 25
$-1.2M
Q4 24
$-5.2M
Q3 24
$-583.0K
Q2 24
$-1.4M
Q1 24
$-3.6M
FCF Margin
QRHC
QRHC
SLNO
SLNO
Q4 25
1.7%
Q3 25
8.9%
65.8%
Q2 25
6.5%
-38.6%
Q1 25
-1.8%
Q4 24
-7.4%
Q3 24
-0.8%
Q2 24
-2.0%
Q1 24
-4.9%
Capex Intensity
QRHC
QRHC
SLNO
SLNO
Q4 25
0.1%
Q3 25
0.0%
0.0%
Q2 25
0.0%
0.0%
Q1 25
0.2%
Q4 24
0.6%
Q3 24
0.1%
Q2 24
3.1%
Q1 24
2.6%
Cash Conversion
QRHC
QRHC
SLNO
SLNO
Q4 25
Q3 25
1.67×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

QRHC
QRHC

Services$55.8M95%
Product Sales And Other$3.1M5%

SLNO
SLNO

Segment breakdown not available.

Related Comparisons